Todd A. Brugel

Development of Orally Bioavailable Bicyclic Pyrazolones as Inhibitors of Tumor Necrosis Factor-α Production

Michael P. Clark, Steven K. Laughlin, Matthew J. Laufersweiler et al. · Journal of Medicinal Chemistry · 2004 · 131 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)

M. Sabat, John C. VanRens, Matthew J. Laufersweiler et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 68 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Michael P. Clark, Kelly M. George, Roger G. Bookland et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 55 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-α) production

Steven K. Laughlin, Michael P. Clark, Jane F. Djung et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 54 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Intramolecular Diels−Alder Cyclizations of (<i>E</i>)-1-Nitro-1,7,9-decatrienes:  Synthesis of the AB Ring System of Norzoanthamine

David R. Williams, Todd A. Brugel · Organic Letters · 2000 · 53 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8